Wen Chyi Shyu - Concepedia

Author

Wen Chyi Shyu

Bristol-Myers Squibb (United States)

Also Known As

W C Shyu, W SHYU, W. C. SHYU, W. C. Shyu, W. Shyu, W.C Shyu, W.C. Shyu, WEN CHYI SHYU, Wen C. Shyu, Wen Chyi Shyu

121

Publications

2.1K

Citations

H-Index

Concepts

All Affiliations

Bristol-Myers Squibb (United States)Bristol-Myers Squibb (Germany)Takeda (Japan)Millennium Engineering and Integration (United States)

About

Wen Chyi Shyu is an author at Bristol-Myers Squibb (United States) specializing in medicine, pharmacology, and pharmacokinetics.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	20	28	1.2K
2	Health Sciences	5	5	244
3	Allergy	3	3	141
4	Natural Sciences	2	2	89
5	Engineering	1	1	94

Wen Chyi Shyu

Publications

1.8K

Citations

H-Index

Page 1

	Year	Citations
Genome-wide hypomethylation in hepatocellular carcinogenesis. Chih Hung Lin, Sen‐Yung Hsieh, I-Shyan Sheen, PubMed Normal Liver TissuesChromatinGenome-wide HypomethylationHepatologyHcc Samples	2001	244
Pharmacokinetics of didanosine in patients with acquired immunodeficiency syndrome or acquired immunodeficiency syndrome—related complex Catherine A. Knupp, Wen Chyi Shyu, Raphael Dolin, Clinical Pharmacology & Therapeutics	1991	101
In Vitro Screening of 50 Highly Prescribed Drugs for Thiol Adduct Formation—Comparison of Potential for Drug-Induced Toxicity and Extent of Adduct Formation Jinping Gan, Qian Ruan, Bing He, Chemical Research in Toxicology Pharmaceutical ScienceThiol Adduct Formation—comparisonPharmacotherapyToxicological MechanismOxidative Stress	2009	99
Shift in pH of biological fluids during storage and processing: effect on bioanalysis Aberra Fura, Timothy W. Harper, Hongjian Zhang, Journal of Pharmaceutical and Biomedical Analysis Biological FluidsEngineeringBiochemistrySeparation ScienceBioanalysis	2003	94
High-pressure liquid chromatographic analysis of BMY-28142 in plasma and urine Rashmi H. Barbhaiya, S. Thomas Forgue, Wen Chyi Shyu, Antimicrobial Agents and Chemotherapy Protein PurificationHuman Serum ProteinsBioanalysisAnalytical ChemistryToxicology	1987	92
Multiple-dose phase I study of transnasal butorphanol Wen Chyi Shyu, Kenneth A. Pittman, D. Robinson, Clinical Pharmacology & Therapeutics	1993	74
Biotransformation of irbesartan in man. Theodore J. Chando, Donald W. Everett, A. D. Kahle, PubMed BiologyHuman UrinePlasma RadioactivityHealthy SubjectsBiochemistry	1998	70
Comparison of cefprozil and cefaclor pharmacokinetics and tissue penetration Rashmi H. Barbhaiya, Umesh Shukla, Carol Gleason, Antimicrobial Agents and Chemotherapy Tissue PenetrationElimination Half-lifeBioanalysisSkin Blister FluidMedicine	1990	55
The effects of age and gender on the pharmacokinetics of irbesartan Nimish N. Vachharajani, Wen Chyi Shyu, Robert A. Smith, British Journal of Clinical Pharmacology	1998	51
Oral Bioavailability and Disposition Characteristics of Irbesartan, an Angiotensin Antagonist, in Healthy Volunteers Nimish N. Vachharajani, Wen Chyi Shyu, Theodore J. Chando, The Journal of Clinical Pharmacology	1998	48

Page 1